EP 3589373 A4 20201223 - COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY
Title (en)
COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY
Title (de)
ZUSAMMENSETZUNGEN UND VERFAHREN FÜR DIE IMMUNTHERAPIE
Title (fr)
COMPOSITIONS ET MÉTHODES POUR IMMUNOTHÉRAPIE
Publication
Application
Priority
- US 201762466601 P 20170303
- US 201762484063 P 20170411
- US 201762542402 P 20170808
- US 2018020704 W 20180302
Abstract (en)
[origin: WO2018160993A1] The present invention provides biocircuit systems, effector modules and compositions for cancer immunotherapy. Methods for inducing anti-cancer immune responses in a subject are also provided.
IPC 8 full level
A61P 37/02 (2006.01); A61K 35/00 (2006.01); A61K 39/00 (2006.01); A61K 39/39 (2006.01); A61P 35/00 (2006.01); C07K 14/47 (2006.01); C07K 14/54 (2006.01); C07K 14/55 (2006.01); C07K 14/705 (2006.01); C12N 9/02 (2006.01); C12N 9/06 (2006.01); C12N 9/16 (2006.01); C12N 9/48 (2006.01); C12N 9/64 (2006.01); C12N 9/88 (2006.01); C12N 9/90 (2006.01); C12N 15/62 (2006.01)
CPC (source: EP)
A61K 39/39 (2013.01); A61K 39/4611 (2023.05); A61K 39/4631 (2023.05); A61K 39/464402 (2023.05); A61K 39/464406 (2023.05); A61K 39/464412 (2023.05); A61K 39/464417 (2023.05); A61K 39/464463 (2023.05); A61K 39/464471 (2023.05); A61P 35/00 (2018.01); A61P 37/02 (2018.01); C07K 14/47 (2013.01); C07K 14/4702 (2013.01); C07K 14/54 (2013.01); C07K 14/55 (2013.01); C07K 14/705 (2013.01); C12N 9/003 (2013.01); C12N 9/0055 (2013.01); C12N 9/16 (2013.01); C12N 9/485 (2013.01); C12N 9/6472 (2013.01); C12N 9/88 (2013.01); C12N 9/90 (2013.01); C12N 15/62 (2013.01); C12Y 105/01003 (2013.01); C12Y 301/04053 (2013.01); C12Y 304/14005 (2013.01); C12Y 402/01001 (2013.01); C12Y 502/01008 (2013.01); A61K 2039/55533 (2013.01); A61K 2039/585 (2013.01); A61K 2039/82 (2018.08); A61K 2239/29 (2023.05); A61K 2239/31 (2023.05); C07K 14/7051 (2013.01); C07K 2319/00 (2013.01); C07K 2319/01 (2013.01); C07K 2319/03 (2013.01); C12N 2710/16234 (2013.01); Y02A 50/30 (2018.01)
Citation (search report)
- [Y] US 2014010791 A1 20140109 - WANDLESS THOMAS J [US], et al
- [YD] US 8173792 B2 20120508 - WANDLESS THOMAS J [US], et al
- [Y] ALEXANDRE JUILLERAT ET AL: "Design of chimeric antigen receptors with integrated controllable transient functions", SCIENTIFIC REPORTS, vol. 6, 11 January 2016 (2016-01-11), pages 18950, XP055271820, DOI: 10.1038/srep18950
- See also references of WO 2018160993A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
DOCDB simple family (publication)
WO 2018160993 A1 20180907; AU 2018226857 A1 20190919; CA 3055200 A1 20180907; CN 110913954 A 20200324; EP 3589373 A1 20200108; EP 3589373 A4 20201223; JP 2020511528 A 20200416; JP 2021088598 A 20210610
DOCDB simple family (application)
US 2018020704 W 20180302; AU 2018226857 A 20180302; CA 3055200 A 20180302; CN 201880029032 A 20180302; EP 18761512 A 20180302; JP 2019568591 A 20180302; JP 2021032321 A 20210302